Published Online
on May 23, 2005

A more recent version of this article appeared on May 31, 2005

This Article Full Text (PDF) All Versions of this Article: 111/21/2798    most recent CIRCULATIONAHA.104.516278v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McMillen, T. S. Articles by LeBoeuf, R. C. Search for Related Content PubMed PubMed Citation Articles by McMillen, T. S. Articles by LeBoeuf, R. C. Related Collections Animal models of human disease Pathophysiology Risk Factors Genetically altered mice Other Vascular biology Related Article

Submitted on October 22, 2004
Revised on December 22, 2004
Accepted on December 29, 2004

Expression of Human Myeloperoxidase by Macrophages Promotes Atherosclerosis in Mice

Timothy S. McMillen PhD, Jay W. Heinecke MD, and Renee C. LeBoeuf PhD^*

From the Nutritional Sciences Interdisciplinary Program (T.S.M., R.C.L.) and the Department of Medicine (T.S.M., R.C.L., J.W.H.), University of Washington, Seattle.

^* To whom correspondence should be addressed. E-mail: leboeuf{at}u.washington.edu.

Background--Myeloperoxidase (MPO) colocalizes with macrophages in the human artery wall, and its characteristic oxidation products have been detected in atherosclerotic lesions. Thus, oxidants produced by the enzyme might promote atherosclerosis. However, macrophages in mouse atherosclerotic tissue do not express MPO. Therefore, mice are an inappropriate model for testing the role of MPO in vascular disease. To overcome this problem, we generated and studied transgenic (Tg) mice that contained the human MPO gene.

Methods and Results--We produced human MPO-Tg mice with use of a Visna virus promoter. To confine MPO expression to macrophages, we lethally irradiated LDL receptor-deficient mice and repopulated their bone marrow with cells from wild-type mice or MPO-Tg mice. Despite having similarly high levels of cholesterol after maintenance on a high-fat, high-cholesterol diet, the MPO-Tg animals developed a 2-fold greater atherosclerotic area in the aorta than did mice transplanted with wild-type bone marrow (P=0.00003).

Conclusions--Our observations indicate that expression of human MPO in macrophages promotes atherosclerosis in hypercholesterolemic mice, raising the possibility that the enzyme might be a potential therapeutic target for preventing cardiovascular disease in humans.

Key words: lipoproteins • myeloperoxidase • oxidative stress • atherosclerosis

Related Article:

Issue Highlights
Circulation 2005 111: 2711. [Extract] [Full Text]

This article has been cited by other articles:

				A. M. Vincent, J. M. Hayes, L. L. McLean, A. Vivekanandan-Giri, S. Pennathur, and E. L. Feldman Dyslipidemia-Induced Neuropathy in Mice: The Role of oxLDL/LOX-1 Diabetes, October 1, 2009; 58(10): 2376 - 2385. [Abstract] [Full Text] [PDF]

				J. A. Ronald, J. W. Chen, Y. Chen, A. M. Hamilton, E. Rodriguez, F. Reynolds, R. A. Hegele, K. A. Rogers, M. Querol, A. Bogdanov, et al. Enzyme-Sensitive Magnetic Resonance Imaging Targeting Myeloperoxidase Identifies Active Inflammation in Experimental Rabbit Atherosclerotic Plaques Circulation, August 18, 2009; 120(7): 592 - 599. [Abstract] [Full Text] [PDF]

				S. J. Nicholls and S. L. Hazen Myeloperoxidase, modified lipoproteins, and atherogenesis J. Lipid Res., April 1, 2009; 50(Supplement): S346 - S351. [Abstract] [Full Text] [PDF]

				M. Swee, C. L. Wilson, Y. Wang, J. K. McGuire, and W. C. Parks Matrix metalloproteinase-7 (matrilysin) controls neutrophil egress by generating chemokine gradients J. Leukoc. Biol., June 1, 2008; 83(6): 1404 - 1412. [Abstract] [Full Text] [PDF]

				Y. Kawai, T. Nishikawa, Y. Shiba, S. Saito, K. Murota, N. Shibata, M. Kobayashi, M. Kanayama, K. Uchida, and J. Terao Macrophage as a Target of Quercetin Glucuronides in Human Atherosclerotic Arteries: IMPLICATION IN THE ANTI-ATHEROSCLEROTIC MECHANISM OF DIETARY FLAVONOIDS J. Biol. Chem., April 4, 2008; 283(14): 9424 - 9434. [Abstract] [Full Text] [PDF]

				M. van Leeuwen, M. J.J. Gijbels, A. Duijvestijn, M. Smook, M. J. van de Gaar, P. Heeringa, M. P.J. de Winther, and J. W. C. Tervaert Accumulation of Myeloperoxidase-Positive Neutrophils in Atherosclerotic Lesions in LDLR / Mice Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 84 - 89. [Abstract] [Full Text] [PDF]

				G. Li, A. C. Keenan, J. C. Young, M. J. Hall, Z. Pamuklar, E. M. Ohman, S. R. Steinhubl, and S. S. Smyth Effects of Unfractionated Heparin and Glycoprotein IIb/IIIa Antagonists Versus Bivalirdin on Myeloperoxidase Release From Neutrophils Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1850 - 1856. [Abstract] [Full Text] [PDF]

				M. C. Meuwese, E. S.G. Stroes, S. L. Hazen, J. N. van Miert, J. A. Kuivenhoven, R. G. Schaub, N. J. Wareham, R. Luben, J. J.P. Kastelein, K.-T. Khaw, et al. Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy Individuals: The EPIC-Norfolk Prospective Population Study J. Am. Coll. Cardiol., July 10, 2007; 50(2): 159 - 165. [Abstract] [Full Text] [PDF]

				J. Borawski, B. Naumnik, and M. Mysliwiec Heparin, Myeloperoxidase, and Atherosclerosis: A New Focus on an Old Drug Clinical and Applied Thrombosis/Hemostasis, April 1, 2007; 13(2): 219 - 220. [PDF]

				C. Cuccurullo, A. Iezzi, M. L. Fazia, D. De Cesare, A. Di Francesco, R. Muraro, R. Bei, S. Ucchino, F. Spigonardo, F. Chiarelli, et al. Suppression of Rage as a Basis of Simvastatin-Dependent Plaque Stabilization in Type 2 Diabetes Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2716 - 2723. [Abstract] [Full Text] [PDF]

				J. Yang, Y. Cheng, R. Ji, and C. Zhang Novel model of inflammatory neointima formation reveals a potential role of myeloperoxidase in neointimal hyperplasia Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H3087 - H3093. [Abstract] [Full Text] [PDF]

				L. W. Castellani, J. J. Chang, X. Wang, A. J. Lusis, and W. F. Reynolds Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males J. Lipid Res., July 1, 2006; 47(7): 1366 - 1377. [Abstract] [Full Text] [PDF]

				K. R. Wildsmith, C. J. Albert, D. S. Anbukumar, and D. A. Ford Metabolism of Myeloperoxidase-derived 2-Chlorohexadecanal J. Biol. Chem., June 23, 2006; 281(25): 16849 - 16860. [Abstract] [Full Text] [PDF]

				M. Exner, E. Minar, W. Mlekusch, S. Sabeti, J. Amighi, W. Lalouschek, G. Maurer, C. Bieglmayer, H. Kieweg, O. Wagner, et al. Myeloperoxidase Predicts Progression of Carotid Stenosis in States of Low High-Density Lipoprotein Cholesterol J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2212 - 2218. [Abstract] [Full Text] [PDF]

				J. Takeshita, J. Byun, T. Q. Nhan, D. K. Pritchard, S. Pennathur, S. M. Schwartz, A. Chait, and J. W. Heinecke Myeloperoxidase Generates 5-Chlorouracil in Human Atherosclerotic Tissue: A POTENTIAL PATHWAY FOR SOMATIC MUTAGENESIS BY MACROPHAGES J. Biol. Chem., February 10, 2006; 281(6): 3096 - 3104. [Abstract] [Full Text] [PDF]